Skip to main content
Premium Trial:

Request an Annual Quote

Febit Joins European Sequencing Technology Alliance

NEW YORK (GenomeWeb News) – Febit has joined a European consortium focused on developing DNA sequencing technologies, and plans to advance its gene capturing technology for use with the group's members.

The Revolutionary Approaches and Devices for Nucleic Acid analysis consortium, involving 16 industry and academic research entities and funded by the European Union with €12 million ($15.1 million), is focused on developing faster, more cost-efficient and targeted approaches in comparative genomics.

The HybSelect technology enables capture of specific DNA regions for high-throughput sequencing, allows researchers to operate next-generation sequencers by directing the sequencing process to the regions of interest to the researcher, Febit CSO Peer Stähler said in a statement.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.